SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-139133
Filing Date
2024-05-15
Accepted
2024-05-15 12:00:30
Documents
15
Period of Report
2024-05-15

Document Format Files

Seq Description Document Type Size
1 6-K d832258d6k.htm 6-K 10859
2 EX-99.1 d832258dex991.htm EX-99.1 571173
3 EX-99.2 d832258dex992.htm EX-99.2 13960
4 EX-99.3 d832258dex993.htm EX-99.3 7749
5 EX-99.4 d832258dex994.htm EX-99.4 7950
6 GRAPHIC g832258dsp004.jpg GRAPHIC 212810
7 GRAPHIC g832258dsp005.jpg GRAPHIC 166282
8 GRAPHIC g832258dsp066.jpg GRAPHIC 240879
9 GRAPHIC g832258dsp067.jpg GRAPHIC 203361
10 GRAPHIC g832258g0504032915344.jpg GRAPHIC 5864
11 GRAPHIC g832258g0504032915542.jpg GRAPHIC 2592
12 GRAPHIC g832258g0504032915733.jpg GRAPHIC 2206
13 GRAPHIC g832258g0504032915913.jpg GRAPHIC 1960
14 GRAPHIC g832258page31.jpg GRAPHIC 41550
15 GRAPHIC g832258page63a.jpg GRAPHIC 3167
  Complete submission text file 0001193125-24-139133.txt   1827024
Mailing Address 201-2067 CADBORO BAY RD. VICTORIA A1 V8R 5G4
Business Address 201-2067 CADBORO BAY RD. VICTORIA A1 V8R 5G4 250-590-3968
EUPRAXIA PHARMACEUTICALS INC. (Filer) CIK: 0001581178 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41923 | Film No.: 24948534
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)